{"log_id": 4363550955704069009, "direction": 0, "words_result_num": 55, "words_result": [{"probability": {"variance": 0.015241, "average": 0.939036, "min": 0.459042}, "location": {"width": 386, "top": 207, "height": 25, "left": 150}, "words": "表1:椎体骨折患者的发生率和相对危险性的降低"}, {"probability": {"variance": 0.015102, "average": 0.935654, "min": 0.360921}, "location": {"width": 514, "top": 246, "height": 26, "left": 465}, "words": "安慰剂本品与安慰剂相比的相对危险性(95%C),P"}, {"probability": {"variance": 0, "average": 0.890205, "min": 0.890205}, "location": {"width": 44, "top": 278, "height": 22, "left": 287}, "words": " SOTI"}, {"probability": {"variance": 0.007527, "average": 0.934347, "min": 0.730708}, "location": {"width": 149, "top": 279, "height": 21, "left": 471}, "words": "N=723N=719"}, {"probability": {"variance": 2e-06, "average": 0.998178, "min": 0.995616}, "location": {"width": 206, "top": 310, "height": 24, "left": 200}, "words": "在3年中新发生的体折"}, {"probability": {"variance": 0.020993, "average": 0.910735, "min": 0.394231}, "location": {"width": 360, "top": 311, "height": 24, "left": 474}, "words": "32.8%20.9%41%(27-52),p<0.001"}, {"probability": {"variance": 0.007488, "average": 0.953437, "min": 0.589197}, "location": {"width": 638, "top": 342, "height": 26, "left": 200}, "words": "在第1年中新发生的体骨折11.8%6.1%49%(26-64),p<0.00"}, {"probability": {"variance": 0.003283, "average": 0.97286, "min": 0.661783}, "location": {"width": 632, "top": 374, "height": 25, "left": 201}, "words": "在3年中新发生的临床体骨折17.4%11,3%38%(17-53),p<0.00"}, {"probability": {"variance": 0, "average": 0.978226, "min": 0.978226}, "location": {"width": 71, "top": 407, "height": 20, "left": 274}, "words": " TROPOS"}, {"probability": {"variance": 0.01175, "average": 0.901353, "min": 0.663913}, "location": {"width": 142, "top": 407, "height": 20, "left": 471}, "words": "N=1823N=18"}, {"probability": {"variance": 8.6e-05, "average": 0.994001, "min": 0.971922}, "location": {"width": 204, "top": 438, "height": 22, "left": 201}, "words": "在3年中新发生的体骨折"}, {"probability": {"variance": 0.030412, "average": 0.870192, "min": 0.415884}, "location": {"width": 367, "top": 436, "height": 27, "left": 473}, "words": "2.0%12.5%39(27-29),p<0.001"}, {"probability": {"variance": 0.011804, "average": 0.950823, "min": 0.520562}, "location": {"width": 971, "top": 481, "height": 29, "left": 145}, "words": "入选时年龄超过80岁的患者,将SOT和 TROPOS资料集中分析的结果显示:本品治疗3年后降低了新发生推体骨折的相对危险"}, {"probability": {"variance": 0.013709, "average": 0.932989, "min": 0.566999}, "location": {"width": 538, "top": 509, "height": 23, "left": 148}, "words": "性达32%雷奈酸组的发生率19.1%s.安慰剂纽的发生率26.5%)"}, {"probability": {"variance": 0.006439, "average": 0.95962, "min": 0.53028}, "location": {"width": 974, "top": 537, "height": 26, "left": 144}, "words": "在一项来自会并的 ISOTIATTROPOS研究患者的后验分析中,对于治疗前腰椎和/或股骨颈BMD属于骨质疏松症的范围,未发"}, {"probability": {"variance": 0.017078, "average": 0.947685, "min": 0.41522}, "location": {"width": 970, "top": 563, "height": 27, "left": 147}, "words": "生过资折存在至少一种其他的骨折危险因素的患者(N=176),本品治疗3年后降低这些患者发生第1次体管折的危险性达72"}, {"probability": {"variance": 0.020469, "average": 0.913768, "min": 0.426235}, "location": {"width": 461, "top": 591, "height": 23, "left": 145}, "words": "%(椎体骨折的发生率,雪东酸3.6%VS.安慰剂12.0%"}, {"probability": {"variance": 0.017869, "average": 0.94157, "min": 0.40603}, "location": {"width": 951, "top": 617, "height": 26, "left": 150}, "words": " TROPOS研究中的亚组患者,需要特别的医疗照硕并存在骨折的高危险性定义为:股骨颈BMD≤-3SD生产厂商的范園"}, {"probability": {"variance": 0.030603, "average": 0.890941, "min": 0.356868}, "location": {"width": 969, "top": 643, "height": 28, "left": 143}, "words": "采用 NHANES III方法相当于2.4SD)以及年龄≥74岁(n=1977,40%的 TROPOS研究人群》在这个人群中,与安慰齐"}, {"probability": {"variance": 0.01906, "average": 0.922374, "min": 0.397607}, "location": {"width": 539, "top": 671, "height": 22, "left": 144}, "words": "相比,经过本品的3年治疗,髋部骨折的危险性降低了36(详见表2)"}, {"probability": {"variance": 0.006656, "average": 0.957733, "min": 0.63729}, "location": {"width": 649, "top": 704, "height": 23, "left": 145}, "words": "麦2:在BMD≤2.4SD以及年龄≥岁的患者部骨折发生率和相对危险性的降低"}, {"probability": {"variance": 0.007884, "average": 0.952373, "min": 0.693247}, "location": {"width": 413, "top": 752, "height": 25, "left": 461}, "words": "安慰剂本品与安慰剂相比的相对危险性"}, {"probability": {"variance": 0, "average": 0.872663, "min": 0.872663}, "location": {"width": 71, "top": 783, "height": 23, "left": 276}, "words": " TROPOS"}, {"probability": {"variance": 0.024766, "average": 0.93517, "min": 0.465577}, "location": {"width": 149, "top": 784, "height": 23, "left": 453}, "words": "N=995N-982"}, {"probability": {"variance": 0.004975, "average": 0.951364, "min": 0.778572}, "location": {"width": 206, "top": 816, "height": 23, "left": 184}, "words": "3年中新发生的髓部骨折"}, {"probability": {"variance": 0, "average": 0.920364, "min": 0.920364}, "location": {"width": 20, "top": 819, "height": 20, "left": 481}, "words": "9"}, {"probability": {"variance": 0, "average": 0.999633, "min": 0.999415}, "location": {"width": 20, "top": 818, "height": 22, "left": 568}, "words": "3%"}, {"probability": {"variance": 0.015911, "average": 0.829098, "min": 0.55183}, "location": {"width": 281, "top": 805, "height": 36, "left": 715}, "words": "3(0—590.06"}, {"probability": {"variance": 4.4e-05, "average": 0.992702, "min": 0.983974}, "location": {"width": 87, "top": 859, "height": 25, "left": 149}, "words": "药理毒理"}, {"probability": {"variance": 0, "average": 0.740733, "min": 0.740733}, "location": {"width": 28, "top": 855, "height": 22, "left": 823}, "words": "4"}, {"probability": {"variance": 0.000168, "average": 0.988607, "min": 0.967404}, "location": {"width": 72, "top": 890, "height": 22, "left": 144}, "words": "药理作用"}, {"probability": {"variance": 4e-06, "average": 0.992104, "min": 0.989359}, "location": {"width": 73, "top": 918, "height": 22, "left": 143}, "words": "作用机理"}, {"probability": {"variance": 0.006322, "average": 0.97325, "min": 0.438728}, "location": {"width": 973, "top": 944, "height": 26, "left": 144}, "words": "体外研究发现,冒奈酸在骨组织培养中增加骨生成,在骨细胞培养中提高成骨细胞前体的复制和胶的合成;通过减少破骨"}, {"probability": {"variance": 0.00249, "average": 0.973709, "min": 0.778174}, "location": {"width": 644, "top": 972, "height": 27, "left": 144}, "words": "细胞的分化和吸收活性来减少骨重吸收。从而恢复骨转化的平衡,有利于新骨生成"}, {"probability": {"variance": 0.030446, "average": 0.90201, "min": 0.361288}, "location": {"width": 623, "top": 1001, "height": 24, "left": 144}, "words": "在大鼠模型中,东酸锶增加了骨小梁的质量、数量和厚度;从而改善了骨强度"}, {"probability": {"variance": 0.009616, "average": 0.954183, "min": 0.601108}, "location": {"width": 973, "top": 1028, "height": 26, "left": 144}, "words": "在治疗过的动物或人体的骨组织中,主要吸附在晶体表面,在新形成骨的碳石灰体中替代少许的钙。雷酸不改变骨品"}, {"probability": {"variance": 0.013464, "average": 0.951374, "min": 0.401589}, "location": {"width": 974, "top": 1057, "height": 24, "left": 143}, "words": "体的特征。在期临床研究中,需奈酸钢每日2克服用长达6个月后获得的骨活检资料未观察到雷态酸对骨质量和矿化"}, {"probability": {"variance": 4e-06, "average": 0.996953, "min": 0.993588}, "location": {"width": 110, "top": 1085, "height": 23, "left": 141}, "words": "产生有害作用"}, {"probability": {"variance": 0.013021, "average": 0.925743, "min": 0.537419}, "location": {"width": 974, "top": 1110, "height": 26, "left": 143}, "words": "锶在骨组织的分布(洋见[药代动力学】)以及其(与钙相比)使X-线吸收增加的联合作用导致双能X射线吸收骨密度仪(DXA)"}, {"probability": {"variance": 0.01069, "average": 0.959607, "min": 0.409872}, "location": {"width": 976, "top": 1137, "height": 27, "left": 141}, "words": "浏定的矿物密度(BMD)放大。现有资料提示,使用本品2克/天治疗3年后,大约50%的BMD测量变化是由这些因素引起"}, {"probability": {"variance": 0.010925, "average": 0.960055, "min": 0.455581}, "location": {"width": 977, "top": 1166, "height": 28, "left": 140}, "words": "的,因此在使用本品治疗中解释BMD的改变时要考志到这些因素,根据研究结果,在Ⅲ期临床研究中,在已证明本品治疗的"}, {"probability": {"variance": 0.006736, "average": 0.972952, "min": 0.513002}, "location": {"width": 973, "top": 1196, "height": 25, "left": 143}, "words": "抗骨折疗效的情况下,与治疗前相比本品治疗后所测定的腰推平均BMD每年增加了4%,股骨颈增加了2%:治疗3年后分别"}, {"probability": {"variance": 0.044339, "average": 0.904774, "min": 0.353995}, "location": {"width": 206, "top": 1224, "height": 22, "left": 149}, "words": "加了13%15%15%6%"}, {"probability": {"variance": 0.011412, "average": 0.958716, "min": 0.446278}, "location": {"width": 972, "top": 1251, "height": 26, "left": 144}, "words": "在I期临床研究中,与安慰剂相比,从治疗后3个月开始至治疗后3年,骨形成的生化指标(骨特异性碱性磷酸酶和型前胶原C"}, {"probability": {"variance": 0.015658, "average": 0.924124, "min": 0.513324}, "location": {"width": 788, "top": 1279, "height": 24, "left": 142}, "words": "端肽)升高,而骨吸收的生化指标血清I塑胶原交联C末端肽(CTX)和尿交联N末端肽(NTX))降低"}, {"probability": {"variance": 0.021143, "average": 0.92636, "min": 0.412845}, "location": {"width": 976, "top": 1306, "height": 25, "left": 141}, "words": "作为奈酸锶的继发性药理作用,发现钙和甲状旁腺激素(PTH)的血浆浓度轻度降低:血磷和总碱生磷酸酶的活性升高,但未"}, {"probability": {"variance": 8.5e-05, "average": 0.994697, "min": 0.969754}, "location": {"width": 163, "top": 1336, "height": 21, "left": 142}, "words": "观察到任何临床后果"}, {"probability": {"variance": 7.8e-05, "average": 0.993465, "min": 0.978464}, "location": {"width": 71, "top": 1365, "height": 20, "left": 144}, "words": "毒理研究"}, {"probability": {"variance": 0.016277, "average": 0.949464, "min": 0.478267}, "location": {"width": 606, "top": 1390, "height": 24, "left": 139}, "words": "临床前安全性药理学、遗传毒性、致潜力研究未发现本品对人体有特殊危险"}, {"probability": {"variance": 0.020139, "average": 0.931195, "min": 0.425957}, "location": {"width": 978, "top": 1419, "height": 25, "left": 139}, "words": "啮齿类动物长期服用大剂量的雪酸钯导致骨和牙齿的异赏,主要包括自发性骨折和矿化延迟。这些作用发生时,动物骨中锶"}, {"probability": {"variance": 0.000483, "average": 0.988716, "min": 0.905274}, "location": {"width": 493, "top": 1446, "height": 24, "left": 140}, "words": "的水平比临床患者长期服药时高出2-3倍,且治疗停止后可逆转"}, {"probability": {"variance": 0.028933, "average": 0.922891, "min": 0.366747}, "location": {"width": 976, "top": 1476, "height": 25, "left": 140}, "words": "在大鼠和家兔的发育毒理学研究中,重酸想导致子代动物骨和牙齿的异常(如弯曲的长骨和波浪形的肋骨)。在大鼠中,停药"}, {"probability": {"variance": 3.6e-05, "average": 0.995698, "min": 0.979917}, "location": {"width": 192, "top": 1505, "height": 22, "left": 139}, "words": "8周后这些作用得到逆转"}, {"probability": {"variance": 2.3e-05, "average": 0.996118, "min": 0.987327}, "location": {"width": 115, "top": 1541, "height": 26, "left": 148}, "words": "药代动力学"}, {"probability": {"variance": 0.018731, "average": 0.945449, "min": 0.350141}, "location": {"width": 975, "top": 1568, "height": 27, "left": 139}, "words": "奈酸钢是由两个稳定的原子和一个雷奈酸分子组成,有机组成部分使得在分子重量、药代动力学和药品耐受性方面达到最"}], "language": 3}